文献速递心脑血管急症消化、代谢与肾脏急症

缺血性卒中后两种低密度脂蛋白胆固醇目标的比较

A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
PubMed 文献 · N Engl J Med · 2019-11-18
一句话结论缺血性卒中或TIA伴动脉粥样硬化证据者,LDL胆固醇目标<70 mg/dL较90–110 mg/dL降低主要心血管事件风险(调整HR 0.78)。

在法国和韩国开展的平行组试验,纳入近3个月内缺血性卒中或15天内TIA且有脑血管或冠状动脉粥样硬化证据的患者2860例,随机分入LDL胆固醇目标<70 mg/dL组或90–110 mg/dL组,均接受他汀和/或依折麦布治疗。中位随访3.5年,达到的LDL胆固醇均值分别为65 mg/dL和96 mg/dL。主要复合终点(缺血性卒中、心肌梗死、导致紧急冠状动脉或颈动脉血运重建的新症状、心血管原因死亡)在低目标组121例(8.5%) vs 高目标组156例(10.9%),调整HR 0.78(95%CI 0.61–0.98;P=0.04)。颅内出血和新诊断糖尿病发生率两组无显著差异。

要点

  • 缺血性卒中或TIA伴动脉粥样硬化证据者,LDL目标<70 mg/dL组主要心血管事件8.5% vs 90–110 mg/dL组10.9%(调整HR 0.78,95%CI 0.61–0.98;P=0.04)。
  • 两组均接受他汀、依折麦布或两者联用,低目标组达到的LDL均值65 mg/dL,高目标组96 mg/dL。
  • 颅内出血和新诊断糖尿病发生率两组无显著差异。
  • 试验因行政原因在预设385个终点事件中发生277个时提前终止。
  • 中位随访3.5年,共2860例患者,每组1430例。

适用人群与场景

  • 近3个月内缺血性卒中或15天内TIA,且有脑血管或冠状动脉粥样硬化证据的患者。
  • 来自法国和韩国的平行组试验人群。

诊断标准与关键阈值

  • 低目标组:LDL胆固醇目标<70 mg/dL(1.8 mmol/L)。
  • 高目标组:LDL胆固醇目标范围90–110 mg/dL(2.3–2.8 mmol/L)。

处置流程与药物剂量

  • 所有患者接受他汀、依折麦布或两者联用。
  • 低目标组目标LDL胆固醇<70 mg/dL(1.8 mmol/L),高目标组目标90–110 mg/dL(2.3–2.8 mmol/L)。

研究设计与关键结果

  • 平行组试验,纳入2860例,每组1430例,中位随访3.5年;基线LDL均值135 mg/dL(3.5 mmol/L)。
  • 达到的LDL均值:低目标组65 mg/dL(1.7 mmol/L) vs 高目标组96 mg/dL(2.5 mmol/L)。
  • 主要复合终点(缺血性卒中、心肌梗死、导致紧急冠状动脉或颈动脉血运重建的新症状、心血管原因死亡):低目标组121例(8.5%) vs 高目标组156例(10.9%),调整HR 0.78(95%CI 0.61–0.98;P=0.04)。
  • 颅内出血和新诊断糖尿病发生率两组无显著差异。
  • 试验因行政原因在预设385个终点事件中发生277个时提前终止。

证据类型、等级与局限

  • 随机平行组试验(Treat Stroke to Target,NCT01252875),由法国卫生部等资助。
  • 局限:试验因行政原因在预设385个终点事件中发生277个时提前终止。

对床旁实践的改变

  • 对于缺血性卒中或TIA伴动脉粥样硬化证据的患者,作者结论认为LDL胆固醇目标<70 mg/dL者后续心血管事件风险低于目标90–110 mg/dL者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The use of intensive lipid-lowering therapy by means of statin medications is recommended after transient ischemic attack (TIA) and ischemic stroke of atherosclerotic origin. The target level for low-density lipoprotein (LDL) cholesterol to reduce cardiovascular events after stroke has not been well studied.

METHODS: In this parallel-group trial conducted in France and South Korea, we randomly assigned patients with ischemic stroke in the previous 3 months or a TIA within the previous 15 days to a target LDL cholesterol level of less than 70 mg per deciliter (1.8 mmol per liter) (lower-target group) or to a target range of 90 mg to 110 mg per deciliter (2.3 to 2.8 mmol per liter) (higher-target group). All the patients had evidence of cerebrovascular or coronary-artery atherosclerosis and received a statin, ezetimibe, or both. The composite primary end point of major cardiovascular events included ischemic stroke, myocardial infarction, new symptoms leading to urgent coronary or carotid revascularization, or death from cardiovascular causes.

RESULTS: A total of 2860 patients were enrolled and followed for a median of 3.5 years; 1430 were assigned to each LDL cholesterol target group. The mean LDL cholesterol level at baseline was 135 mg per deciliter (3.5 mmol per liter), and the mean achieved LDL cholesterol level was 65 mg per deciliter (1.7 mmol per liter) in the lower-target group and 96 mg per deciliter (2.5 mmol per liter) in the higher-target group. The trial was stopped for administrative reasons after 277 of an anticipated 385 end-point events had occurred. The composite primary end point occurred in 121 patients (8.5%) in the lower-target group and in 156 (10.9%) in the higher-target group (adjusted hazard ratio, 0.78; 95% confidence interval, 0.61 to 0.98; P = 0.04). The incidence of intracranial hemorrhage and newly diagnosed diabetes did not differ significantly between the two groups.

CONCLUSIONS: After an ischemic stroke or TIA with evidence of atherosclerosis, patients who had a target LDL cholesterol level of less than 70 mg per deciliter had a lower risk of subsequent cardiovascular events than those who had a target range of 90 mg to 110 mg per deciliter. (Funded by the French Ministry of Health and others; Treat Stroke to Target ClinicalTrials.gov number, NCT01252875.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Amarenco P, Kim JS, Labreuche J, et al. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke. N Engl J Med. 2019. PMID: 31738483. doi:10.1056/NEJMoa1910355

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。